Clinical Trials for Cixutumumab

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticCOGADVL1221
12/13/2012
A Phase II Study of Cixutumumab (IMC-A12; IND# 100947) in Combination with Temsirolimus (IND# 61010) in Pediatric Patients with Recurrent or Refractory Solid Tumors

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.